Control Bionics (ASX:CBL) Total Tax Payable : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Total Tax Payable?

Control Bionics's Total Tax Payable for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Control Bionics Total Tax Payable Historical Data

The historical data trend for Control Bionics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Total Tax Payable Chart

Control Bionics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Total Tax Payable

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Tax Payable	Get a 7-Day Free Trial			-	-	-	-	-

Control Bionics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Control Bionics Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Control Bionics's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics (ASX:CBL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Bourke Road, Suite 5.01, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.